In the brain, ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate glutamatergic neurotransmission and, when intensely activated, can induce excitotoxic cell death. In addition to their ionotropic properties, however, AMPA receptors have been functionally coupled to a variety of signal transduction events involving Src-family kinases, G-proteins, and the mitogen-activated protein kinase (MAPK). In the present study, we tested whether AMPA receptors are linked to appropriate signaling events in order to prevent neuronal injury and/or enhance recovery. 
INTRODUCTION
AMPA-type glutamate receptors have been studied for their role in synaptic plasticity, learning and memory, and several types of neuropathologies. Glutamate is the major excitatory amino acid in the brain and this neurotransmitter facilitates the fast component of excitatory communication through AMPA receptors (19) . AMPA receptors not only express ionotropic properties but also transmit extracellular signals to the nucleus of cultured neurons through the MAPK signaling pathway (18, 28, 37, 38) . The connection between AMPA receptors and MAPK expands the potential roles for glutamatergic responses. The MAPK cascade is involved in a myriad of processes including hippocampalmediated learning (4, 12) and the neuroprotective actions of nerve growth factor (21) , estrogen (11, 34) , and other hormones (13, 17, 21) . While AMPA receptors provide the necessary hippocampal activity for memory encoding and retrieval (29) , it is not known whether such glutamatergic transmission participates in neuroprotective survival signaling.
While excessive glutamatergic activity through AMPA receptors is no doubt a critical feature of the excitotoxic damage associated with ischemia (14, 27, 33) , low-level stimulation of AMPA receptors by endogenous glutamate has been shown to enhance the survival of cultured hippocampal neurons (10) . In addition, McKinney et al. (26) recently found evidence that AMPA receptor activation by spontaneous vesicular release of glutamate promotes synaptic maintenance in hippocampus. Because AMPA stimulation elevates trophic signaling through a MAPK-dependent pathway (18) , we expected that AMPA receptors might activate repair mechanisms following pathogenic insults. Here, we demonstrate that AMPA receptors can be positively modulated to promote the MAPK signaling pathway and, correspondingly, to prevent fatal levels of cellular damage after pathogenic insults in hippocampal slice cultures and in the adult brain.
MATERIALS AND METHODS
Organotypic hippocampal slice cultures. SpragueDawley rat litters (Charles River Laboratories, Wilmington, Massachusetts) were housed in accordance with guidelines from the National Institutes of Health. Animals 11-12 days postnatal were sacrificed by isoflurane anesthesia and decapitation. Transverse slices of hippocampus (400 m) were then quickly prepared, maintained on Millicell-CM inserts (Millipore Corporation, Bedford, MA), and periodically supplied with fresh media composed of 50% basal medium Eagle, 25% Earle's balanced salts, 25% horse serum, and defined supplements (6, 8) . Slices were allowed to mature for 15-20 days in culture before used in experiments.
MAPK activation. Slice cultures were treated with or without 100 M AMPA for 0.5-3 min in the absence or presence of 30 M CNQX or 50 M AP5. Other slices received 100 M 1-(quinoxalin-6-ylcarbonyl)piperidine (CX516) for 5-60 min in the absence or presence of 50 M PD 98059. The culture inserts were then rapidly flooded with ice-cold homogenization buffer containing 0.32 M sucrose, 5 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM EGTA, 1 M okadaic acid, 10 nM calyculin A, and the protease inhibitors aprotinin, leupeptin, bestatin, E-64, pepstatin A (each at 2 g/mL), and 4-(2-aminoethyl)benzenesulfonyl fluoride (0.3 mM). Each condition used 8 -10 groups of six to eight slices each. MAPK activation was assessed with antibodies that recognized the phosphorylated catalytic core of active ERK isoforms.
Induction of neuropathology. To test for potentiated neurodegeneration, cultured slices were treated with CNQX (30 M) or the MEK inhibitor U0126 (20 M) under control or serum-free conditions for 24 h. For induction of excitotoxic pathology, slices were preincubated for 2 h with or without CX516, at a concentration of 100 M unless stated otherwise, and then subjected to a 15-min AMPA (100 M) or 5-h TMT (100 M) exposure. After removal of the toxins, the cultures were subsequently quenched with media containing 40 M CNQX and 20 M MK-801 for 20 min. Fresh media with or without CX516 was then supplied and the slices maintained in culture for 1-10 days before being prepared for immunoblotting and immunocytochemistry. To induce lysosomal dysfunction, 60 M chloroquine was infused into slice cultures that were preincubated with or without 100 M CX516. The chloroquine treatment continued for 3-9 days in the absence or presence of CX516. Treatment groups (n ϭ 4-6 per time point) were staggered so that all slices were harvested on the same day, at which time they were washed thoroughly in serum-free media and prepared for subsequent analyses. All compounds were freshly solubilized and the solutions were titrated to pH 7.3 and sterile filtered.
Immunoblot analysis. Slice cultures were gently removed with a soft brush and homogenized in groups of six to eight using ice-cold homogenization buffer. Protein content was determined with a BSA standard and equal aliquots of the slice samples were denatured in sampling buffer for 5 min at 100°C, then separated by 4 -16% SDS-PAGE and blotted to nitrocellulose. Immunodetection was accomplished by incubation overnight at 4°C with anti-active MAPK (Cell Signaling, Beverly, MA), monoclonal anti-ERK1/ERK2 (Zymed Laboratories, South San Francisco, CA), antiactive JNK2 (Promega, Madison, WI), affinity-purified antibodies to calpain-mediated spectrin fragment BDP N (9), monoclonal anti-synaptophysin (Boehringer Mannheim, Indianapolis, IN), and affinity-purified antibodies to the AMPA receptor subunit GluR1 (7). Secondary antibody incubation utilized anti-IgG-alkaline phosphatase conjugates, and color development used the 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium substrate system. Color development of immunoreactive bands was terminated before maximal intensity was reached in order to avoid saturation and to ensure a linear relationship with increasing amount of sample protein. Bands were scanned at high resolution to determine integrated density with BIOQUANT software (R & M Biometrics, Nashville, TN).
Histology. Slices were rinsed with 0.1 M phosphate buffer (PB), pH 7.4, and fixed for 2 h in cold PB plus 4% paraformaldehyde. Slices were then cryoprotected and carefully removed from the insert, and serial sections were cut at 20-m thickness and mounted on gelatincoated slides. Sections were immunolabeled with antiactive MAPK and anti-BDP N using the avidin-biotinperoxidase technique (Vector Laboratories, Burlingame, CA) and 3,3Ј-diaminobenzidine as the chromogen (6, 8) . To measure area of BDP N immunostaining (m 2 ), threshold digitization was used utilizing the BIO-QUANT image analysis system linked to an Olympus AX70 microscope. Thresholding was set so that Ͼ90% of the punctate immunoreactivity in the neuropil registered as area stained in AMPA-treated slices. The percentage of total immunostaining above threshold was similar in slices treated with or without CX516. The established threshold criteria consistently found no staining in control slices. For cell counts, sections from slices were stained with cresyl violet. The average number of neurons across three viewfields of 6.5 ϫ 10 4 m 2 per slice was obtained using the BIOQUANT system, and percentage loss was calculated by comparing treated vs untreated slice groups. In CA1, adjacent viewfields were selected in CA1b and the initial area of CA1c. For CA3, three adjacent viewfields were selected from the zone immediately before the dentate gyrus envelope. Granule cells of the stratum granulosum were counted in three adjacent viewfields selected from the middle segment of the inner blade. Pyramidal neurons with characteristic morphological features, reduced cytoplasmic staining, and dense nuclear staining with inclusions were counted as pyknotic nuclei. Means Ϯ SEM were determined from 8 -16 slices per group and compared by t test or ANOVA.
NF-B activation. Nuclei were prepared from cultured slices homogenized in ice-cold nuclear extract buffer consisting of 20 mM HEPES (pH 7.9), 100 mM NaCl, 1.5 mM MgCl 2 , 0.5 mM EDTA, 0.7% IGEPAL CA-630, 10% glycerol, 2 g/mL leupeptin, 5 g/mL aprotinin, and freshly added 0.1 mM PMSF and 0.5 mM DTT. Centrifugation at 6500 rpm was used to wash the pellet twice, and then the pellet material was resuspended and incubated in high-salt buffer containing 0.5 M KCl for 30 min at 4°C. After a final centrifugation at 13,000 rpm for 30 min, the supernatant was collected and protein concentration determined with a BSA standard. Equal protein (7.5 g) was added to the electrophoretic mobility shift assay mixture containing 166 g/mL poly(dIdC) and 50 g/mL BSA. The mixture was incubated on ice for 20 min and then at room temperature for 15 min with the P 32 -labeled consensus oligonucleotide recognized by NF-B (Promega). Supershift analyses included incubating samples for 20 min with antibodies to the p50 subunit (Santa Cruz Biotechnology, Santa Cruz, CA) before DNA-protein complexes were resolved by 4% native PAGE and visualized by Kodak X-OMAT film autoradiography.
In vivo excitotoxicity. In adult male rats under pentobarbital anesthesia (8 -10 per treatment), 50 nmol AMPA in 2 L PBS were coinjected with 0 -900 nmol CX516 slowly into the right striatum. Control animals received injections of vehicle only or 600 nmol CX516. Lesion extent (mean volume Ϯ SEM) was determined 24 h postinjection by magnetic resonance imaging utilizing a Biospec 47/15 spectrometer (Bruker, Karlsruhe, Germany). The radiofrequency probe was an Alderman-Grant-type resonator with an inner diameter of 40 mm and 50 mm in length. Eight coronal sections of 1.5 mm thickness were analyzed between 2.5 and 13 mm anterior to the intraaural line. Image analysis was conducted in a blind manner and with the following parameters: 60-ms spin echo delay, 2-s repetition delay, and a spatial resolution of 0.16 ϫ 0.16 mm 2 (viewfield of 40 ϫ 40 mm 2 ). The lesion area in each section was measured by semiautomated segmentation based on intensity thresholding, and the lesion volume was calculated from the pixel dimension and total thickness of sections. At 7 days postinjection, the animals were sacrificed and the cortices and striata from ipsilateral and contralateral hemispheres were rapidly dissected, weighed, and prepared for enzymatic assays. Tissue homogenates were prepared in 0.5% Triton X-100, 0.1 mM pyridoxal phosphate, and 1 mM mercaptoethanol and assessed for choline acetyltransferase (CAT) and glutamic acid decarboxylase (GAD) activities (16, 24) . The percent change in enzymatic activity in the injected vs uninjected sides of the brains was determined (mean Ϯ SEM).
Statistical analyses. Mean integrated densities for antigens in slice samples treated with or without an inhibitor were compared using unpaired, two-tailed t tests. Ampakine-induced immunostaining of phospho-ERK2 was compared to the integrated density from control samples using the unpaired, two-tailed t test. The difference between the mean area of BDP N immunostaining in AMPA-insult slices vs control slices was determined by the two-tailed t test. Regional analyses of immunostained area or percentage cell loss were assessed by one-way ANOVA. Neuroprotective effects on the mean number of neurons or pyknotic nuclei per 6.5 ϫ 10 4 -m 2 viewfield were determined by unpaired t tests. Dose-dependent studies assessed protection against an excitotoxic insult in vitro or in vivo across three dosages of Ampakine using the one-way ANOVA.
FIG. 1.
AMPA receptors are linked to the activation of ERK1/ ERK2 MAPK in hippocampal slice cultures. Untreated slices and slices exposed to AMPA for 2 min in the absence or presence of CNQX or AP5 were assessed for the phosphorylated active forms of ERK1 and ERK2. (b) Slices were treated with the AMPA receptor modulator CX516 for 60 min in the absence or presence of the inhibitor of MEK activation PD 98059. (c) Slices were treated with CX516 and AMPA for the noted times and mean integrated density of the phosphorylated active form of ERK2 was determined by immunoblot (ϮSEM). Unpaired, two-tailed t tests: *P Ͻ 0.005 compared to untreated slices; ϩϩP ϭ 0.01 compared to AMPA-treated slices.
FIG. 2. (above) ERK1/ERK2
MAPK activation in hippocampal neurons. Control slices (a, b), slices treated with AMPA for 3 min (c) or with Ampakine CX516 for 5 min (d), and slices subjected to a 3-min AMPA exposure followed by 20 min with CX516 (e, f ) were fixed, sectioned, and stained with anti-active MAPK antibodies. Subfield CA1 is shown at high power in (b), (d), and (f ). DG, dentate gyrus; sg, stratum granulosum; sp, stratum pyramidale; sr, stratum radiatum. Scale bar: a, c, e, 500 m; b, d, f, 50 m.
RESULTS
MAPK isoforms (ERK1/2) are activated when phosphorylated on Thr and Tyr residues of their catalytic core by the kinase MEK. Stimulation of AMPA receptors in hippocampal slice cultures caused rapid MAPK activation as indicated by enhanced staining of ERK1 (p44) and ERK2 (p42) with an antibody that specifically recognizes the dually phosphorylated isoforms (Fig. 1a) . Increased MAPK activation found after as little as 30 s was similar to that measured after 2-3 min of AMPA exposure, and the effect was blocked by the AMPA receptor antagonist CNQX (P ϭ 0.01) but not by the N-methyl-D-aspartate (NMDA) receptor antagonist AP5. These results indicate that stimulation of AMPA receptors modulates the MAPK signaling pathway in hippocampus.
AMPA receptor activation can be positively influenced by allosteric modulators that increase glutamate-mediated neurotransmission (2, 3, 35) . Such positive modulation by the Ampakine CX516 also increased the levels of active ERK1/ERK2 (Fig. 1b) and this induction was completely blocked by PD 98059 (Ϫ122 Ϯ 11%, mean Ϯ SEM; P Ͻ 0.0001), a specific inhibitor of MEK activation (1) . Immunodetection of total MAPK (active and inactive ERK1/ERK2) in parallel immunoblot samples indicated that no change in MAPK protein levels was produced by AMPA (data not shown) or CX516 alone (Fig. 1b) during the time of kinase activation. In addition, the activation of MAPK was not associated with modulation of the c-Jun Nterminal protein kinase (JNK) pathway. AMPA treatment in cultured hippocampal slices had no effect on the level of phosphorylated active JNK2 enzyme (98 Ϯ 17% of levels in control slices), nor were the levels changed by positive modulation of AMPA receptors (104 Ϯ 19%).
Next, we tested whether allosteric modulation promotes AMPA-induced activation of MAPK. Slice cultures treated with CX516 for 5-60 min exhibited an approximate twofold increase in activated ERK2 levels (P Ͻ 0.0001; Fig. 1c ). The Ampakine treatment was able to sustain the enhanced phosphorylation of MAPK isoforms for several hours (data not shown), at a level similar to the twofold increase produced by brief AMPA exposure (Fig. 1c) . Interestingly, CX516 further enhanced the AMPA-induced MAPK activation by 75%, thereby causing a total increase in activated ERK2 of 3.5-fold over the control levels (P Ͻ 0.0005; Fig. 1c) . While only faint anti-active MAPK immunostaining was observed in control slices (Figs. 2a and 2b) , phospho-MAPK-immunopositive cells were abundant in the stratum pyramidale of field CA1 in slices exposed to AMPA for 3 min (noted by arrows in Fig. 2c ). The immunostaining was less intense in the CA3 subfield and the dentate gyrus, and no specific immunoreactivity was detected when the primary antibody was eliminated from the staining procedure. Phospho-MAPK staining in slices incubated with the Ampakine CX516 alone exhibited similar regional selectivity as that produced by AMPA, and the immunoreactivity was primarily restricted to the cytoplasm of pyramidal neurons (Fig. 2d) . The additive effect of CX516 and AMPA was pronounced in field CA1 (Fig. 2e) , where the phospho-MAPK immunostaining appeared to be both somatodendritic and nuclear ( Fig. 2f ; arrows indicate labeled apical dendrites).
FIG. 3.
Inhibition of the AMPA receptor-MAPK pathway promotes neurodegenerative processes. Cultured hippocampal slices were treated with the AMPA receptor antagonist CNQX or with the MEK inhibitor U0126 under control or serum-free conditions for 24 h, and then analyzed by immunoblot for calpain-mediated spectrin breakdown product (BDP) and the AMPA receptor subunit GluR1. 5 , and cell counts were determined for Nissl-stained pyramidal neurons and granule cells in those slices subjected to the AMPA insult only. Specific BDP immunoreactivity was determined by image analysis and percent cell loss was calculated as compared to control slices (mean Ϯ SEM). (c) Counts of pyramidal neurons (left three bars) and pyknotic nuclei (right bars) in area CA1 were determined to assess CX516-mediated neuroprotection. The mean number per 6.5 ϫ 10 4 -m 2 viewfield is shown for each condition (ϮSEM). *P Ͻ 0.01, unpaired t test compared to insult-alone data.
Cell-surface signal transduction through the link between AMPA receptors and MAPK may play a role in neuronal maintenance. In support of this, hippocampal slice cultures were found to be more vulnerable to neurodegeneration when AMPA receptors were blocked by CNQX for 24 h. Spectrin breakdown product BDP, a marker of excitotoxicity and other types of neurodegenerative events (36) , was specifically labeled with antibodies to the cleavage site recognized by the calcium-dependent protease calpain (9) . CNQX increased the level of spectrin BDP resulting from serum deprivation, and caused a corresponding ϳ50% decline in the carboxyl-terminal staining of postsynaptic marker GluR1 (Fig. 3, upper blots) . The serum deprivation-induced damage may involve excitotoxic mechanisms as previously indicated in dopaminergic neurons (31) . CNQX also caused activation of NF-B (Fig.  4) , a transcription factor known to be activated in response to pathogenic episodes (25) . Similar evidence of enhanced vulnerability was found when the MAPK component of the AMPA receptor-MAPK pathway was disrupted with the MEK inhibitor U0126. Spectrin breakdown exhibited a pronounced increase and the GluR1 labeling decreased by 60% when serum deprivation was combined with U0126 for 24 h (Fig. 3, lower  blots) . MEK inhibition alone also caused NF-B activation of similar magnitude as that produced by the withdrawal of serum (Fig. 4) . These data indicate that the AMPA receptor-MAPK link is important for cellular maintenance.
Since disruption of the AMPA receptor-MAPK pathway potentiated neurodegeneration, we tested whether enhancing this pathway promotes neuroprotective compensatory signals. For this purpose, we used the Ampakine modulator CX516 to enhance the AMPA receptor-MAPK pathway in the cultured hippocampal slice preparation. Slice cultures were exposed to the agonist AMPA for 15 min, and then the intense neuronal stimulation was rapidly quenched with glutamate receptor antagonists before slices were monitored for cellular damage. Immunocytochemical analysis with antibodies to calpain-mediated spectrin BDP revealed that CA1 neurons and dendritic puncta exhibit marked levels of cytoskeletal proteolysis 24 -36 h after the excitotoxic insult (Fig. 5, middle) . A separate group of slices was preincubated with the allosteric modulator CX516 and continually exposed to the Ampakine during the AMPA treatment and postinsult period. As shown in the bottom panels of Fig. 5 , CX516 caused a dramatic decrease in the number of neurons exhibiting cytoskeletal damage after the recovery period. Total BDP immunostaining was significantly reduced in both the stratum pyramidale layer (P Ͻ 0.01) and the synapse-rich dendritic zone of the stratum radiatum (P Ͻ 0.03) as determined by image analysis.
Cytoskeletal degradation resulting from the excitotoxic exposure was associated with cell death. Cresyl violet-stained sections from hippocampal slice cultures revealed a decrease in CA1 neuron density as well as an increase in pyknotic nuclei 24 h postinsult (Fig. 6a) . Upon examining the three hippocampal subfields (Fig.  6b) , CA1-selective damage was evident with regards to both BDP immunostaining (ANOVA: P ϭ 0.01) and percent cell loss (P ϭ 0.001). Thus, a correspondence exists between the vulnerability to spectrin breakdown and cell death, suggesting that once a certain threshold of cytoskeletal damage is surpassed, the likelihood of cellular recovery is reduced. Related to this, the ability of the Ampakine modulator CX516 to reduce the extent of cytoskeletal breakdown after an excitotoxic insult indeed corresponds with its ability to prevent neuronal death and pyknotic changes (Figs. 6a and 6c) .
The neuroprotective action of Ampakine CX516 was tested for selectivity in hippocampal slice cultures. As in the case against the excitotoxic action of AMPA, CX516 promoted recovery from exposure to TMT, a potent neurotoxin that initiates seizures and selective damage to hippocampal field CA3 by the overstimulation of glutamate receptors (9, 15, 20) . Slice samples were prepared 24 h postinsult and analyzed for BDP, synaptophysin, and the AMPA receptor subunit GluR1 (Fig. 7a) . CX516 almost completely eliminated the spectrin breakdown and the reductions in pre-and postsynaptic markers produced by a 5-h TMT exposure. The neuroprotectant action was dose-dependent and similar in extent to that produced against AMPAinduced excitotoxicity (Fig. 7b) . Cytoskeletal protection was evident against both types of toxic exposures (ANOVA: P Ͻ 0.0001 each) when comparing blot samples from insulted slices (n ϭ 14-27 samples) with those that also received CX516 (n ϭ 10 -17). Ampakine modulation also enhanced synaptic maintenance in a dose-dependent manner in the TMT-insult (P Ͻ 0.0001) and AMPA-insult slices (P ϭ 0.01), resulting in synaptic marker levels similar to those found in control slice cultures (n ϭ 18-22). These results are of particular significance because CX516 was not infused into the slices until after the 5-h insult in the TMT experiment, whereas it was preincubated with slices before the AMPA insult. When AMPA receptor modulation was initiated after the 15-min AMPA exposure, the resulting reduction in cytoskeletal breakdown (Ϫ70%; P Ͻ 0.001) and recovery of synaptophysin (91%; P Ͻ 0.001) were comparable to the protection elicited by the preincubation protocol.
The above data indicate that modulation of AMPA receptors and the AMPA receptor-MAPK pathway elicits protection against pathogenic events involving the excitotoxic activation of glutamate receptors. Surprisingly, the allosteric modulation had no protective effect against nonexcitotoxic pathology. That is, the gradual loss of synaptic markers that occurs with lysosomal perturbation (6) was not influenced by CX516. Slice cultures incubated with the lysosomal inhibitor chloroquine exhibited steady declines in synaptophysin and GluR1 labeling after 3-9 days of treatment, and the declines were not attenuated by a 1-day preincubation and regular application of fresh CX516 (Fig.  7c) . Six groups of slices treated with CX516 alone for 9 days expressed normal levels of the synaptic markers. More extensive dose-response analyses will be required to fully address possible differences in CX516 protection in acute vs chronic insult models.
Further studies were conducted to test whether positive modulation of AMPA receptors elicits protection
FIG. 5.
Positive modulation of AMPA receptors by CX516 promotes cytoskeletal repair. Cultured slices were untreated (control) or subjected to a 15-min exposure to AMPA (insult) as detailed under Materials and Methods. The third group of slices had CX516 present throughout the experiment beginning 2 h prior to the insult. Slices were analyzed for calpain-mediated spectrin breakdown product 36 h postinsult. Field CA1 is shown at high power on the right. DG, dentate gyrus; sp, stratum pyramidale; sr, stratum radiatum. Scale bar: left, 300 m; right, 40 m.
against excitotoxicity in vivo. In order to initiate an excitotoxic insult in adult rats, 50 nmol of AMPA were locally applied to the right striatum with an injection track through the cortex. MRI analyses conducted 24 h later showed that the induced excitotoxicity produced marked unilateral damage (see arrow in Fig. 8b ), while no lesion was evident in animals injected with vehicle only (Fig. 8a) . Besides the expected damage in the striatum, administered AMPA extending into the injection track caused additional lesion formation in the cortex. When the Ampakine CX516 was coinjected with the excitotoxin, the lesion extent was dramatically reduced (Fig. 8c) . The neuroprotection was found to be significant and dose-dependent (analysis of variance: P Ͻ 0.02), attenuating the AMPA-induced lesion size by as much as 64% (Fig. 8e) . As a control, CX516 injected alone caused no damage, in contrast to the sizable lesion volume produced by AMPA (see Fig. 8d ). To assess long-term neuroprotection, ipsilateral and contralateral brain areas were dissected 7 days postinjection and enzyme markers for cholinergic (CAT) and GABAergic neurons (GAD) were measured. Withinanimal comparisons found that the neuronal markers were significantly reduced in the lesioned vs unlesioned hemispheric tissue by 46 -72% (P Ͻ 0.01). Corresponding with the MRI data, the enzyme reductions occurred in both the striatum and the adjacent cortical tissue. As shown in Fig. 8f , the decreases in CAT and GAD activities were completely attenuated by CX516 in the striatum (ANOVA: P Ͻ 0.0001 for both) and were significantly reduced in the neighboring cortical region as well (P Ͻ 0.001 and P Ͻ 0.005, respectively). Thus, Ampakine modulation elicits lasting protection against an excitotoxic insult.
DISCUSSION
The data presented indicate that glutamatergic activity through AMPA receptors is important for cell survival. Inhibition of AMPA receptors reduces cell growth (30) and causes an increased rate of neurodegeneration in cultured neurons (10) , results consistent with those reported here regarding proteolytic responses and NF-B activation in organotypic hippocampal slice cultures. The slice cultures offer the advantage that they exhibit stable features of the adult brain and, more importantly, they respond to pathogenic insults in the same way as found in vivo (5) . Thus, the present report suggests that the same synaptic signals that help determine the composition of the developing brain are involved in the maintenance of mature brain tissue.
Enhanced glutamatergic transmission by the infusion of glutamate or AMPA has been shown to increase neuronal survival (10), attenuate apoptosis (23), and to prevent synaptic deterioration produced by deafferentation (26) . Our results with the allosteric modulator CX516 indicate that AMPA receptor activation, including the low levels produced by spontaneous glutamate release, can be intensified in such a way as to strengthen related survival processes. Spectrin breakdown measures were valuable in evaluating structural repair after an excitotoxic exposure and, as expected, synaptic maintenance and cell survival correlated with the cytoskeletal protection. However, the survival systems activated through the modulation of AMPA receptors are selective with respect to the neuroprotection they elicit. Ampakine CX516 was assessed across different types of pathologies and its protective action was found to reduce the damage resulting from CA1-and CA3-targeting insults which involve the over- stimulation of glutamatergic receptors. In contrast, CX516 had no effect on another pathogenic mechanism, lysosomal dysfunction, which does not involve excitotoxic activity. The glutamate-mediated survival response, thus, can be exploited to prevent serious injury from a specific class of neuropathogenesis.
The signal transduction mechanism that translates AMPA receptor activity into survival signals specifically involves the ERK1/ERK2 MAPK. As shown, allosteric modulation promotes the AMPA receptors' ability to activate the MAPK signaling pathway in hippocampal neurons. While the AMPA receptor-MAPK pathway was evident in all hippocampal subfields, it was most apparent in field CA1. CX516-mediated modulation of the receptors after an excitotoxic insult protected those pyramidal neurons that exhibited enhanced levels of MAPK activation. MAPK's role in survival signaling was further supported by the fact that inhibition of either component of the AMPA receptor-MAPK pathway promotes cytoskeletal vulnerability and NF-B responses.
The neuroprotection results using the cultured hippocampal slice suggest that the functional link between AMPA receptors and MAPK is important for injury-induced compensatory responses in the adult brain. In vivo studies also implicate glutamatergic and MAPK activity in neuronal protection. For example, trisomy 16 mice, an animal model of Down syndrome, are reported to have a defect in a glutamate-mediated trophic response, resulting in accelerated cell death of hippocampal neurons (10) . In addition, the MAPK pathway is necessary for the neuroprotection induced by sublethal preconditioning ischemia (32) . As shown in the present study, Ampakine modulation of glutamatergic transmission protected the striatum and cortex from excitotoxic damage in the adult rat. In addition to the reduction in lesion extent, enzymatic markers measured 1 week after the insult indicated that the neuroprotection was not restricted to the neuronal type targeted by the Ampakine compound. Cholinergic and GABAergic neurons were completely protected in the striatum where the bulk of the Ampakine CX516 was coinjected with the excitotoxin. The extent of AMPA extending into the cortical injection track also caused sizable decreases in the neuronal markers, and CX516 attenuated these reductions. Expectedly, CX516 was higher in concentration in the striatum vs the cortex as indicated by the higher degree of neuroprotection elicited in the striatal area as compared to that found in cortical tissue. These findings suggest that glutamatergic communication between surviving neurons is vital for their full recovery and long-term maintenance after periods of excitotoxicity. Injury-induced compensatory responses through the AMPA receptor-MAPK signaling pathway may involve brain-derived neurotrophic factor (BDNF). AMPA receptor activation has been shown to increase BDNF mRNA in a manner dependent upon MAPK signaling (18) . The same type of allosteric modulation of AMPA receptors used in the present report was also found to enhance BDNF expression in hippocampal slice cultures and in vivo (22) . BDNF has a well-documented effect on neuronal maintenance. Interestingly, BDNFinduced cell survival has been shown to require the MAPK signaling pathway in neuronal cultures deprived of survival factors (13) and, more significantly, in an animal model of ischemic brain injury (17) . Thus, AMPA receptors appear to be linked to endogenous protection mechanisms in order to reduce the risk from the inherent danger of excitotoxic episodes such as those related to ischemia and stroke.
